Loss of the Chromosomal Region 10q23-25 in Prostate Cancer

Cancer Research

Volumn 55, Issue 21, 1995, Pages 4800-4803

  Gray, Ian C ^a   Spurr, Nigel K ^a   Phillips, Stewart M A ^b   Neoptolemos, John P ^b   Lee, Susan J ^c   Weissenbach, Jean ^d  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

^d GÉNÉTHON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 10Q; CHROMOSOME LOSS; CHROMOSOME MAP; CONFORMATION; DELETION MUTANT; DNA POLYMORPHISM; DNA SEQUENCE; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR SUPPRESSOR GENE;

AGED; AGED, 80 AND OVER; ALLELES; BASE SEQUENCE; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 10; COMPARATIVE STUDY; DNA, NEOPLASM; DNA, SATELLITE; DNA-BINDING PROTEINS; FLUORESCENCE; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; HETEROZYGOTE; HUMAN; MALE; MIDDLE AGE; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM STAGING; PROSTATIC NEOPLASMS; SUPPORT, NON-U.S. GOV'T;

EID: 0028874590     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Cannon-Albright, L., and Eeles, R. Progress in prostate cancer. Nat. Genet., 9: 336–338, 1995.
2. Lundgren, R., Mandahl, N., Heim, S., Limon, J., Henrikson, H., and Mitelman, F. Cytogenetic analysis of 57 primary prostatic adenocarcinomas. Genes Chromosomes & Cancer, 4: 16–24, 1992.
3. Arps, S., Rodewald, A., Schmalenberger, B., Carl, P., Bressel, M., and Kastendieck, H. Cytogenetic survey of 32 cancers of the prostate. Cancer Genet. Cytogenet., 66: 93–99, 1993.
4. Zervos, S. J., Gyuris, J., and Brent, R. Mxil, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell, 72: 223–232, 1993.
5. Eagle, L. R., Yin, X., Brothman, A. R., Williams, B. J., Atkin, N. B., and Prochown-ick, E. V. Mutation of the Mxil gene in prostate cancer. Nat. Genet., 9: 249–255, 1995.
6. Phillips, S. M. A., Morton, D. G., Lee, S. J., Wallace, D. M. A., and Neoptolemos, J. P. Loss of heterozygosity of the retinoblastoma and adenomatous polyposis susceptibility gene loci and in chromosomes 10p, lOq, and 16q in human prostate cancer. Br. J. Urol., 73: 390–395, 1994.
7. Gyapay, G., Morissette, J., Vignal, A., Dib, C., Fizames, C., Millasseau, P., Marc, S., Bernadi, G., Lathrop, M., and Weissenbach, J. The 1993–1994 Genethon human genetic linkage map. Nat. Genet., 7: 246–339, 1994.
8. Orita, M., Iwahana, H., Kanazawa, H., Hayashi, K., and Sekiya, T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc. Natl. Acad. Sci. USA, 86: 2766–2770, 1989.
9. Union Internationale Contre Le Cancer. TNM Classification of Malignant Tumours. Geneva: International Union Against Cancer, 1978.
10. Parsons, R., Li, G.-M., Longley, M. J., Fang, W., Papadopoulos, N., Jen, J., de la Chapelle, A., Kinzler, K. W., Vogelstein, B., and Modrich, P. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell, 75: 1227–1236, 1993.
11. Gray, I. C., Nobile, C., Moresu, R., Ford, S., and Spurr, N. K. A 2.4 megabase physical map spanning the CYP2C gene cluster on chromosome 10q24. Genomics 28: 328–332, 1995.
12. Rocchi, M., Covone, A., Romeo, G., Faraonio, R., and Colantuoni, V. Regional mapping of RBP4 to 10q23–24 and RBP1 to 3q21–22 in man. Somatic Cell Mol. Genet., 75: 185–190, 1989.
13. Inoue, K., Inazawa, J., Suzuki, Y., Shimada, T., Yamazaki, H., Guengerich, F. P., and Abe, T. Fluorescence in-situ hybridization analysis and chromosomal localization of 3 human cytochrome-p450–2c genes (cyp2c8, 2c9 and 2c10) at 10q24.1. Jpn. J. Hum. Genet., 39: 337–343, 1994.
14. Cohen, D., Chumakov, I., and Weissenbach, J. A first generation physical map of the human genome. Nature (Lond.), 366: 698–701, 1993.
15. Parmiter, A. H., Balaban, G., Clark, W. H. J., and Nowell, P. C. Possible involvement of the chromosome region 10q24-q26 in early stages of melanocyte neoplasia. Cancer Genet. Cytogenet., 30: 313–317, 1988.
16. Ransom, D. T., Ritland, S. R., Moertel, C. A., Dahl, R. J., O'Fallon, J. R., Scheithauer, B. W., Kimmel, D. W., Kelly, P. J., Olopade, O. I., Diaz, M. O., and Jenkins, R. B. Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytomas. Genes Chromosomes & Cancer, 5: 357–374, 1992.
17. Rasheed, B. K. A., Fuller, G. N., Friedman, A. H., Bigner, D. D., and Bigner, S. H. Loss of heterozygosity for lOq loci in human gliomas. Genes Chromosomes & Cancer, 5: 75–82, 1992.
18. Speaks, S. L., Sanger, W. G., Masih, A. S., Harrington, D. S., Hess, M., and Armitage, J. O. Recurrent abnormalities of chromosome bands 10q23-q25 in non-Hodgkin's lymphoma. Genes Chromosomes & Cancer, 5: 239–243, 1992.
19. Fults, D., and Pedone, C. Deletion mapping of the long arm of chromosome 10 in glioblastoma multiforme. Genes Chromosomes & Cancer, 7: 173–177, 1993.
20. Karlbom, A. E., James, C. D., Boethius, J., Cavenee, W. K., Collins, V. P., Nordenskjold, M., and Larsson, C. Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10. Hum. Genet., 92: 169–174, 1993.
21. Herbst, R. A., Weiss, J., Ehnis, A., Cavanee, W. K., and Arden, K. C. Loss of heterozygosity for 10q22–10qter in malignant melanoma progression. Cancer Res., 54:3111–3114, 1994.